|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - NovoCure Ltd (NVCR)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-07-10 Sale |
2019-07-12 4:04 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
5,000 | $64.83 | $324,155 | 74,504 (Direct) |
View |
| 2019-06-28 Sale |
2019-07-02 4:12 pm |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
187,500 | $62.15 | $11,653,125 | 445,811 (Direct) |
View |
| 2019-06-27 Sale |
2019-06-28 6:55 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
11,175 | $60.3 | $673,852 | 65,037 (Direct) |
View |
| 2019-06-19 Sale |
2019-06-21 4:06 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
12,500 | $60 | $750,000 | 88,712 (Direct) |
View |
| 2019-06-19 Sale |
2019-06-21 4:05 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
25,000 | $60.02 | $1,500,500 | 94,504 (Direct) |
View |
| 2019-06-19 Sale |
2019-06-21 4:03 pm |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
25,000 | $61.46 | $1,536,500 | 283,311 (Direct) |
View |
| 2019-06-19 Sale |
2019-06-21 4:01 pm |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
110,868 | $60 | $6,652,080 | 296,542 (Direct) |
View |
| 2019-06-18 Sale |
2019-06-19 4:16 pm |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
190,338 | $59.37 | $11,300,367 | 448,649 (Direct) |
View |
| 2019-06-11 Sale |
2019-06-13 4:16 pm |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
47,271 | $55.16 | $2,607,615 | 288,747 (Direct) |
View |
| 2019-06-10 Sale |
2019-06-12 4:13 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
1,130 | $55.05 | $62,212 | 76,272 (Direct) |
View |
| 2019-06-10 Sale |
2019-06-12 4:12 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
5,000 | $55.05 | $275,266 | 74,504 (Direct) |
View |
| 2019-06-06 Sale |
2019-06-10 4:13 pm |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
5,999 | $54.79 | $328,661 | 191,673 (Direct) |
View |
| 2019-06-05 Sale |
2019-06-06 4:10 pm |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
17,500 | $54.14 | $947,485 | 203,174 (Direct) |
View |
| 2019-06-03 Sale |
2019-06-05 4:33 pm |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
35,000 | $52.62 | $1,841,741 | 203,174 (Direct) |
View |
| 2019-05-30 Sale |
2019-06-03 4:08 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Chairman |
48,100 | $53.07 | $2,552,523 | 846,463 (Direct) |
View |
| 2019-05-29 Sale |
2019-05-31 4:12 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Chairman |
1,900 | $53.1 | $100,881 | 894,563 (Direct) |
View |
| 2019-05-29 Sale |
2019-05-31 4:11 pm |
NovoCure Ltd | NVCR | PHILLIPS CHARLES G III Director |
95,100 | $52.17 | $4,961,198 | 62,607 (Direct) |
View |
| 2019-05-10 Sale |
2019-05-14 4:08 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
5,000 | $49.79 | $248,950 | 65,000 (Direct) |
View |
| 2019-05-08 Sale |
2019-05-10 4:13 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Chairman |
31,460 | $47.37 | $1,490,386 | 896,463 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-07-10 Exercise |
2019-07-12 4:04 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
5,000 | $3.44 | 74,504 (Direct) |
View |
| 2019-07-10 Exercise |
2019-07-12 4:04 pm |
N/A 2021-09-14 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
5,000 | $3.44 | 74,504 (Direct) |
View |
| 2019-07-05 Option Award |
2019-07-09 4:26 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
764 | $27.81 | 76,976 (Direct) |
View |
| 2019-07-05 Option Award |
2019-07-09 4:25 pm |
N/A N/A |
NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel |
696 | $27.81 | 53,900 (Direct) |
View |
| 2019-07-05 Option Award |
2019-07-09 4:23 pm |
N/A N/A |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM CFO |
454 | $27.81 | 87,179 (Direct) |
View |
| 2019-07-05 Option Award |
2019-07-09 4:22 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
471 | $27.81 | 258,782 (Direct) |
View |
| 2019-06-28 Exercise |
2019-07-02 4:12 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
187,500 | $7.15 | 445,811 (Direct) |
View |
| 2019-06-28 Exercise |
2019-07-02 4:12 pm |
N/A 2027-02-21 |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
187,500 | $7.15 | 445,811 (Direct) |
View |
| 2019-06-19 Exercise |
2019-06-21 4:06 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
12,500 | $11.85 | 88,712 (Direct) |
View |
| 2019-06-19 Exercise |
2019-06-21 4:06 pm |
N/A 2027-05-02 |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
12,500 | $11.85 | 88,712 (Direct) |
View |
| 2019-06-19 Exercise |
2019-06-21 4:05 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
25,000 | $3.44 | 94,504 (Direct) |
View |
| 2019-06-19 Exercise |
2019-06-21 4:05 pm |
N/A 2021-09-14 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
25,000 | $3.44 | 94,504 (Direct) |
View |
| 2019-06-19 Exercise |
2019-06-21 4:03 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
25,000 | $11.46 | 283,311 (Direct) |
View |
| 2019-06-19 Exercise |
2019-06-21 4:03 pm |
N/A 2026-02-24 |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
25,000 | $11.46 | 283,311 (Direct) |
View |
| 2019-06-19 Exercise |
2019-06-21 4:01 pm |
N/A N/A |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
110,868 | $22 | 296,542 (Direct) |
View |
| 2019-06-19 Exercise |
2019-06-21 4:01 pm |
N/A 2025-10-01 |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
110,868 | $22 | 296,542 (Direct) |
View |
| 2019-06-18 Exercise |
2019-06-19 4:16 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
190,338 | $14.37 | 448,649 (Direct) |
View |
| 2019-06-18 Exercise |
2019-06-19 4:16 pm |
N/A 2025-02-23 |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
190,338 | $14.37 | 448,649 (Direct) |
View |
| 2019-06-11 Exercise |
2019-06-13 4:16 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
16,835 | $14.37 | 288,747 (Direct) |
View |
| 2019-06-11 Exercise |
2019-06-13 4:16 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
30,436 | $14.37 | 288,747 (Direct) |
View |
| 2019-06-11 Exercise |
2019-06-13 4:16 pm |
N/A 2025-02-23 |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
16,835 | $14.37 | 288,747 (Direct) |
View |
| 2019-06-11 Exercise |
2019-06-13 4:16 pm |
N/A 2025-02-23 |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
30,436 | $14.37 | 288,747 (Direct) |
View |
| 2019-06-10 Exercise |
2019-06-12 4:12 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
5,000 | $3.44 | 74,504 (Direct) |
View |
| 2019-06-10 Exercise |
2019-06-12 4:12 pm |
N/A 2021-09-14 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
5,000 | $3.44 | 74,504 (Direct) |
View |
| 2019-06-06 Exercise |
2019-06-10 4:13 pm |
N/A N/A |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
5,999 | $7.15 | 191,673 (Direct) |
View |
| 2019-06-06 Exercise |
2019-06-10 4:13 pm |
N/A 2027-02-21 |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
5,999 | $7.15 | 191,673 (Direct) |
View |
| 2019-06-05 Exercise |
2019-06-06 4:10 pm |
N/A N/A |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
17,500 | $7.15 | 203,174 (Direct) |
View |
| 2019-06-05 Exercise |
2019-06-06 4:10 pm |
N/A 2027-02-21 |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
17,500 | $7.15 | 203,174 (Direct) |
View |
| 2019-06-03 Exercise |
2019-06-05 4:33 pm |
N/A N/A |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
17,500 | $7.15 | 203,174 (Direct) |
View |
| 2019-06-03 Exercise |
2019-06-05 4:33 pm |
N/A N/A |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
17,500 | $7.15 | 203,174 (Direct) |
View |
| 2019-06-03 Exercise |
2019-06-05 4:33 pm |
N/A 2027-02-21 |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
17,500 | $7.15 | 203,174 (Direct) |
View |
| 2019-06-03 Exercise |
2019-06-05 4:33 pm |
N/A 2027-02-21 |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
17,500 | $7.15 | 203,174 (Direct) |
View |
| 2019-05-29 Exercise |
2019-05-31 4:11 pm |
N/A N/A |
NovoCure Ltd | NVCR | PHILLIPS CHARLES G III Director |
50,000 | $6.72 | 62,607 (Direct) |
View |
| 2019-05-29 Exercise |
2019-05-31 4:11 pm |
N/A N/A |
NovoCure Ltd | NVCR | PHILLIPS CHARLES G III Director |
21,500 | $11.39 | 62,607 (Direct) |
View |
| 2019-05-29 Exercise |
2019-05-31 4:11 pm |
N/A N/A |
NovoCure Ltd | NVCR | PHILLIPS CHARLES G III Director |
23,600 | $12.3 | 62,607 (Direct) |
View |
| 2019-05-29 Exercise |
2019-05-31 4:11 pm |
N/A 2022-09-28 |
NovoCure Ltd | NVCR | PHILLIPS CHARLES G III Director |
50,000 | $6.72 | 62,607 (Direct) |
View |
| 2019-05-29 Exercise |
2019-05-31 4:11 pm |
2017-05-04 2026-05-04 |
NovoCure Ltd | NVCR | PHILLIPS CHARLES G III Director |
21,500 | $11.39 | 62,607 (Direct) |
View |
| 2019-05-29 Exercise |
2019-05-31 4:11 pm |
2018-05-10 2027-05-09 |
NovoCure Ltd | NVCR | PHILLIPS CHARLES G III Director |
23,600 | $12.3 | 62,607 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:25 pm |
N/A N/A |
NovoCure Ltd | NVCR | HILLEMAN JERYL L Director |
3,359 | $0 | 6,340 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:25 pm |
N/A 2029-05-22 |
NovoCure Ltd | NVCR | HILLEMAN JERYL L Director |
6,340 | $51.36 | 6,340 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:24 pm |
N/A N/A |
NovoCure Ltd | NVCR | Hung David Director |
3,359 | $0 | 6,340 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:24 pm |
N/A 2029-05-22 |
NovoCure Ltd | NVCR | Hung David Director |
6,340 | $51.36 | 6,340 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:20 pm |
N/A N/A |
NovoCure Ltd | NVCR | McCoy Sherilyn S Director |
3,359 | $0 | 6,340 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:20 pm |
N/A 2029-05-22 |
NovoCure Ltd | NVCR | McCoy Sherilyn S Director |
6,340 | $51.36 | 6,340 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:18 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
3,359 | $0 | 69,504 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:18 pm |
N/A 2029-05-22 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
6,340 | $51.36 | 69,504 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:17 pm |
N/A N/A |
NovoCure Ltd | NVCR | VERNON W ANTHONY Director |
3,359 | $0 | 258,589 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:17 pm |
N/A 2029-05-22 |
NovoCure Ltd | NVCR | VERNON W ANTHONY Director |
6,340 | $51.36 | 258,589 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:14 pm |
N/A N/A |
NovoCure Ltd | NVCR | PHILLIPS CHARLES G III Director |
3,359 | $0 | 9,504 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:14 pm |
N/A 2029-05-22 |
NovoCure Ltd | NVCR | PHILLIPS CHARLES G III Director |
6,340 | $56.36 | 9,504 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:13 pm |
N/A N/A |
NovoCure Ltd | NVCR | Madden Martin J. Director |
3,359 | $0 | 12,265 (Direct) |
View |
| 2019-05-22 Option Award |
2019-05-24 4:13 pm |
N/A 2029-05-22 |
NovoCure Ltd | NVCR | Madden Martin J. Director |
6,340 | $51.36 | 12,265 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-22 4:27 pm |
N/A N/A |
NovoCure Ltd | NVCR | Burkoth William T. Director |
6,145 | $48.87 | 6,145 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-22 4:27 pm |
2019-05-21 N/A |
NovoCure Ltd | NVCR | Burkoth William T. Director |
6,145 | $0 | 6,145 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-22 4:26 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
6,145 | $48.87 | 66,145 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-22 4:26 pm |
2019-05-21 N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
6,145 | $0 | 66,145 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-22 4:25 pm |
N/A N/A |
NovoCure Ltd | NVCR | VERNON W ANTHONY Director |
6,145 | $48.87 | 255,230 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-22 4:25 pm |
2019-05-21 N/A |
NovoCure Ltd | NVCR | VERNON W ANTHONY Director |
6,145 | $0 | 255,230 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-22 4:24 pm |
N/A N/A |
NovoCure Ltd | NVCR | PHILLIPS CHARLES G III Director |
6,145 | $48.87 | 6,145 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-22 4:24 pm |
2019-05-21 N/A |
NovoCure Ltd | NVCR | PHILLIPS CHARLES G III Director |
6,145 | $0 | 6,145 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-22 4:21 pm |
N/A N/A |
NovoCure Ltd | NVCR | Madden Martin J. Director |
8,906 | $48.87 | 8,906 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-22 4:21 pm |
2019-05-21 N/A |
NovoCure Ltd | NVCR | Madden Martin J. Director |
8,906 | $0 | 8,906 (Direct) |
View |
| 2019-05-10 Exercise |
2019-05-14 4:08 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
5,000 | $3.44 | 65,000 (Direct) |
View |
| 2019-05-10 Exercise |
2019-05-14 4:08 pm |
N/A 2021-09-14 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
5,000 | $3.44 | 65,000 (Direct) |
View |
| 2019-05-08 Option Award |
2019-05-10 4:16 pm |
2029-05-08 N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
33,052 | $47.56 | 33,052 (Direct) |
View |
| 2019-05-08 Option Award |
2019-05-10 4:16 pm |
2029-05-08 N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
20,000 | $47.56 | 33,052 (Direct) |
View |
| 2019-05-08 Option Award |
2019-05-10 4:15 pm |
N/A 2029-05-08 |
NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel |
29,320 | $47.56 | 29,320 (Direct) |
View |
| 2019-05-08 Option Award |
2019-05-10 4:15 pm |
N/A 2029-05-08 |
NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel |
20,000 | $47.56 | 29,320 (Direct) |
View |
| 2019-05-08 Option Award |
2019-05-10 4:14 pm |
N/A 2029-05-08 |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM CFO |
36,650 | $47.56 | 36,650 (Direct) |
View |
| 2019-05-08 Option Award |
2019-05-10 4:14 pm |
N/A 2029-05-08 |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM CFO |
20,000 | $47.56 | 36,650 (Direct) |
View |
| 2019-05-08 Option Award |
2019-05-10 4:13 pm |
N/A 2029-05-08 |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Chairman |
115,060 | $47.56 | 896,463 (Direct) |
View |
| 2019-05-08 Option Award |
2019-05-10 4:13 pm |
N/A 2029-05-08 |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Chairman |
35,000 | $47.56 | 896,463 (Direct) |
View |
| 2019-05-08 Option Award |
2019-05-10 4:11 pm |
N/A 2029-05-08 |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
91,515 | $47.56 | 91,515 (Direct) |
View |
| 2019-05-08 Option Award |
2019-05-10 4:11 pm |
N/A 2029-05-08 |
NovoCure Ltd | NVCR | Ambrogi Michael J. COO |
20,000 | $47.56 | 91,515 (Direct) |
View |
| 2019-05-08 Option Award |
2019-05-10 4:10 pm |
N/A 2029-05-08 |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
115,060 | $47.56 | 115,060 (Direct) |
View |
| 2019-05-08 Option Award |
2019-05-10 4:10 pm |
N/A 2029-05-08 |
NovoCure Ltd | NVCR | Danziger Asaf CEO |
35,000 | $47.56 | 115,060 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Mon, 15 Jul 2019 23:28:43 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |